Diovan Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)
Conditions:   Breast Cancer;   Neoplasm, Breast;   Breast Diseases;   Antihypertensive Agents;   Sacubitril/Valsartan;   Angiotensin II Type 1 Receptor Blockers;   Angiotensin Receptor Antagonists;   Molecular Mechanisms of Pharmacological Action;   Heart Failure;   Cardiac Toxicity;   Cancer, Therapy-Related;   Cancer Therapy-Related Cardiac Dysfunction;   Cardiotoxicity Intervention:   Drug: Sacubitril-valsartan Sponsors:   Silesian Centre for Heart Diseases;   Medical Research Agency Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 19, 2022 Category: Research Source Type: clinical trials